Notice: This company has been marked as potentially delisted and may not be actively trading. Onconova Therapeutics (ONTX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period TRAW Traws Pharma, Inc.July 20, 2024 | seekingalpha.comOnconova and Trawsfynydd merge to form Traws PharmaApril 4, 2024 | uk.investing.comTraws Pharma Full Year 2023 Earnings: Beats ExpectationsApril 4, 2024 | finance.yahoo.comNewtown’s Onconova Therapeutics Secures $14 Million and New CEO in Merger with TrawsfynyddApril 3, 2024 | msn.comOnconova Acquires Trawsfynydd To Form Traws PharmaApril 2, 2024 | markets.businessinsider.comTraws Pharma Announces New Employee Inducement GrantsApril 2, 2024 | globenewswire.comOnconova to Unveil New Rigosertib Study Results at Cancer Research MeetingMarch 12, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX) and Biogen (BIIB)March 11, 2024 | markets.businessinsider.comOnconova Therapeutics’ Rigosertib Poster Selected for AACR 2024March 8, 2024 | finance.yahoo.comOnconova Therapeutics' Rigosertib Poster Selected for AACR 2024March 8, 2024 | globenewswire.comOnconova Therapeutics Inc (ONTX)February 13, 2024 | investing.comOnconova Therapeutics, Inc. (ONTX)January 23, 2024 | finance.yahoo.comOnconova Therapeutics Stock (NASDAQ:ONTX) Dividends: History, Yield and DatesDecember 21, 2023 | benzinga.comOnconova stock falls 10% on preclinical data for lymphoma drugDecember 12, 2023 | msn.comOnconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell LymphomaDecember 12, 2023 | finance.yahoo.comOnconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’sDecember 8, 2023 | finance.yahoo.comOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity ConferenceNovember 28, 2023 | finance.yahoo.comOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call TranscriptNovember 16, 2023 | finance.yahoo.comOnconova Therapeutics, Inc.: Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 16, 2023 | finanznachrichten.deOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comOnconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023November 7, 2023 | finance.yahoo.comOnconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCLNovember 2, 2023 | benzinga.comOnconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCLNovember 2, 2023 | finance.yahoo.comPromising Developments in Onconova Therapeutics’ Drug Narazaciclib Bolster Buy Rating: An AnalysisOctober 19, 2023 | markets.businessinsider.comPromising Preclinical Narazaciclib Data Presented at MCL MeetingOctober 19, 2023 | finance.yahoo.comOnconova Therapeutics Shares Rise 12% On Skin Cancer Treatment DataOctober 12, 2023 | marketwatch.comEncouraging Rigosertib Data Presented at EADV as Late BreakerOctober 12, 2023 | finance.yahoo.comOnconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV CongressSeptember 28, 2023 | finance.yahoo.comOnconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 6, 2023 | finance.yahoo.comH.C. Wainwright Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)August 11, 2023 | markets.businessinsider.comQ2 2023 Onconova Therapeutics Inc Earnings CallAugust 11, 2023 | finance.yahoo.comOnconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial ResultsAugust 10, 2023 | finance.yahoo.comOnconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023August 3, 2023 | finance.yahoo.comHere's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn SituationJuly 17, 2023 | finance.yahoo.comOnconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant LymphomaJune 14, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Prior RecommendationJune 7, 2023 | msn.comOnconova Therapeutics (ONTX) Receives a Buy from H.C. WainwrightJune 6, 2023 | markets.businessinsider.comOnconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual MeetingJune 5, 2023 | finance.yahoo.comOnconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint BlockadeMay 25, 2023 | finance.yahoo.com8-K: Onconova Therapeutics, Inc.May 17, 2023 | marketwatch.comHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Buy RecommendationMay 16, 2023 | msn.comOnconova Therapeutics (ONTX) Gets a Buy from Noble FinancialMay 16, 2023 | markets.businessinsider.comOnconova Therapeutics, Inc.: Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 16, 2023 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Cara Therapeutics (CARA) and Minerva Neurosciences (NERV)May 16, 2023 | markets.businessinsider.comQ1 2023 Onconova Therapeutics Inc Earnings CallMay 16, 2023 | finance.yahoo.comOnconova Therapeutics: Q1 Earnings InsightsMay 15, 2023 | msn.comOnconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue EstimatesMay 15, 2023 | finance.yahoo.comOnconova Therapeutics (ONTX) Earnings Dates & ReportsMay 15, 2023 | investing.comOnconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finance.yahoo.comOnconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial CancerMay 12, 2023 | finance.yahoo.com Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. ONTX Media Mentions By Week ONTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONTX News Sentiment▼0.000.47▲Average Medical News Sentiment ONTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONTX Articles This Week▼00▲ONTX Articles Average Week Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMRX News ME News CASI News ALLK News EPIX News RENB News CLSD News ACET News FBLG News HOWL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconova Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
